Biotech Values

[CT]

Thanks for taking the time to share all of those thoughts. I'll confess that I had never internalized how sick folks are with eGFR < 15. Your predictions make a lot of sense in that light. Do we know what the average time spent with eGFR <= 15 is, before dialysis is started? Anemia is not your biggest problem at this stage, is it?

Anyway, am I wrong in now concluding that roxa's MACE benefit is right where you would expect (hope) it to be? Prior to kidney failure (15 < eGFR < 60) and also during incident dialysis.

I can't help but come away more positive on roxa after another think through. Maybe I'm forgetting some details of the results presented in early May.